CSEM is a Swiss research and technology organization which delivers advanced technologies and unique R&D services to industry in a wide range of fields. In the field of biotechnology CSEM provides and develops customized solutions for sensors, tools, instrumentation and automation by uniting expertise from the areas of surface treatment, cell culture supports & microcarriers, cell & liquid handling, microfluidics, (bio)sensors, integration, and automation.
Experts in biochemical and molecular bioanalytics, diagnostics, medicional chemistry, pharmacology and toxicology.
Institute of Life Technologies, HES-SO
The Institute of Life Technologies is part of the School of Engineering of the University of Applied Sciences Valais Wallis (HES-SO Valais Wallis). It benefits from the experience and know-how of more than 80 collaborators.
Our research groups, supported by our technological and analytical platforms, develop their activities around four main research axes:
- BIOTECHNOLOGY & SUSTAINABLE CHEMISTRY:
bioprocess engineering, downstream processing, bioanalytics, strain development, sustainable chemistry & energy, renewable bioresources, biocatalysis, biomaterials.
- DIAGNOSTIC SYSTEMS:
Point-of-care diagnostics, immuno-, molecular- and cellular diagnostics, instrumental analytics and biosensor development.
- FOOD AND NATURAL PRODUCTS:
Processing of food and natural products, process development, hygienic design concepts, food microbiology and food safety of total food chain, bioactive compounds and health.
- PEPTIDE AND PROTEIN TECHNOLOGIES:
Discovery and optimization of therapeutic peptides, small scale production of peptides and proteins in microbial and mammalian cells, custom design and synthesis of peptidomimetics, peptide conjugation chemistries, analytical peptide and protein characterization.
Biotechnology: research is oriented towards processes using microorganisms and plant/animal cell cultures for the manufacturing (i.e. synthesis and transformation), decomposition and analysis of substances including molecular and cell biology. The resulting products and processes are applied in pharmaceutical, food and natural resources fields.
Chemistry and biological chemistry: specialized in chemical and biochemical engineering, (bio)chemical measure and sensor technologies as well as specialty chemistry.
Competence Center Personalized Medicine UZH/ETH
DNA Sequencing has changed biomedical research. Now focus is on Medicine: Routine genetic analysis shall make patient-tailored therapies standard. The Competence Center Personalized Medicine UZH/ETH (CC-PM) coordinates and actively supports interdisciplinary research of the University of Zurich, ETH Zurich and the University Hospitals in Zurich in the field of genome-based healthcare.
The Platform for stem cells and regenerative medicine (SCRM; www.stemcellsbern.ch) is a supra-faculty research cluster affiliated with the Department of BioMedical Research (DBMR) at the University of Bern. SCRM comprises 37 member groups in stem cell research from the Medical Faculty and Insel, Bern University Hospital as well as the Vetsuisse and Phil.-nat. Faculties. The SCRM Mission is to support innovative and high quality research at the University of Bern and Insel, Bern University Hospital and efficiently and rapidly transfer basic findings on cell therapy into clinical applications.
The SCRM Platform supports and connects Bernese scientists with activities in stem cell research and regenerative medicine with the goal to foster innovation through support of
young researchers (PhD Retreat, Stem Cell Lunch Seminar; PhD Curriculum in stem cells and regenerative medicine)
exchanges between established Bernese research groups in stem cell research and RegMed (Stem Cell Lunch Seminar; Home page; News Letter)
national and international networking (e.g. Meeting Cell Therapy 2016)